These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 29319606)
1. Disruption of nNOS-NOS1AP protein-protein interactions suppresses neuropathic pain in mice. Lee WH; Li LL; Chawla A; Hudmon A; Lai YY; Courtney MJ; Hohmann AG Pain; 2018 May; 159(5):849-863. PubMed ID: 29319606 [TBL] [Abstract][Full Text] [Related]
2. ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability. Lee WH; Carey LM; Li LL; Xu Z; Lai YY; Courtney MJ; Hohmann AG Mol Pain; 2018; 14():1744806918801224. PubMed ID: 30157705 [TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics. Lee WH; Xu Z; Ashpole NM; Hudmon A; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG Neuropharmacology; 2015 Oct; 97():464-75. PubMed ID: 26071110 [TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats. Carey LM; Lee WH; Gutierrez T; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG Neuroscience; 2017 May; 349():303-317. PubMed ID: 28285942 [TBL] [Abstract][Full Text] [Related]
5. PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model. Sun Z; Meng P; Su C; Ji S; Gao Y; Wang H; Tian J; Li C Toxicol Appl Pharmacol; 2021 Oct; 429():115698. PubMed ID: 34428447 [TBL] [Abstract][Full Text] [Related]
6. Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models. Li LL; Melero-Fernandez de Mera RM; Chen J; Ba W; Kasri NN; Zhang M; Courtney MJ J Neurosci; 2015 May; 35(19):7349-64. PubMed ID: 25972165 [TBL] [Abstract][Full Text] [Related]
7. Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain. Wang W; Mei XP; Wei YY; Zhang MM; Zhang T; Wang W; Xu LX; Wu SX; Li YQ Brain Behav Immun; 2011 Oct; 25(7):1355-66. PubMed ID: 21496481 [TBL] [Abstract][Full Text] [Related]
8. A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABA Li J; Zhang L; Xu C; Shen YY; Lin YH; Zhang Y; Wu HY; Chang L; Zhang YD; Chen R; Zhang ZP; Luo CX; Li F; Zhu DY Theranostics; 2021; 11(12):5970-5985. PubMed ID: 33897893 [TBL] [Abstract][Full Text] [Related]
10. Disrupting nNOS-PSD95 Interaction Improves Neurological and Cognitive Recoveries after Traumatic Brain Injury. Qu W; Liu NK; Wu X; Wang Y; Xia Y; Sun Y; Lai Y; Li R; Shekhar A; Xu XM Cereb Cortex; 2020 Jun; 30(7):3859-3871. PubMed ID: 31989159 [TBL] [Abstract][Full Text] [Related]
11. The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death. Li LL; Ginet V; Liu X; Vergun O; Tuittila M; Mathieu M; Bonny C; Puyal J; Truttmann AC; Courtney MJ J Neurosci; 2013 May; 33(19):8185-201. PubMed ID: 23658158 [TBL] [Abstract][Full Text] [Related]
12. Leptin Contributes to Neuropathic Pain via Extrasynaptic NMDAR-nNOS Activation. Liang Y; Ma Y; Wang J; Nie L; Hou X; Wu W; Zhang X; Tian Y Mol Neurobiol; 2021 Mar; 58(3):1185-1195. PubMed ID: 33099751 [TBL] [Abstract][Full Text] [Related]
13. Targeting PSD95-nNOS interaction by Tat-N-dimer peptide during status epilepticus is neuroprotective in MAM-pilocarpine rat model. Colciaghi F; Nobili P; Cipelletti B; Cagnoli C; Zambon S; Locatelli D; de Curtis M; Battaglia GS Neuropharmacology; 2019 Jul; 153():82-97. PubMed ID: 31047919 [TBL] [Abstract][Full Text] [Related]
14. nNOS-PSD95 interactions activate the PKC-ε isoform leading to increased GluN1 phosphorylation and the development of neuropathic mechanical allodynia in mice. Choi SR; Han HJ; Beitz AJ; Lee JH Neurosci Lett; 2019 Jun; 703():156-161. PubMed ID: 30926374 [TBL] [Abstract][Full Text] [Related]
15. Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors. Smith AE; Xu Z; Lai YY; Kulkarni PM; Thakur GA; Hohmann AG; Crystal JD Behav Brain Res; 2016 May; 305():23-9. PubMed ID: 26909849 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling. Courtney MJ; Li LL; Lai YY Front Cell Neurosci; 2014; 8():252. PubMed ID: 25221472 [TBL] [Abstract][Full Text] [Related]
17. Endogenous nitric oxide inhibits spinal NMDA receptor activity and pain hypersensitivity induced by nerve injury. Chen SR; Jin XG; Pan HL Neuropharmacology; 2017 Oct; 125():156-165. PubMed ID: 28754372 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of neuronal nitric oxide synthase in the periphery promotes pain hypersensitivity after peripheral nerve injury. Kim KH; Kim JI; Han JA; Choe MA; Ahn JH Neuroscience; 2011 Sep; 190():367-78. PubMed ID: 21664432 [TBL] [Abstract][Full Text] [Related]
19. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice. Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide signaling contributes to ectopic orofacial neuropathic pain. Sugiyama T; Shinoda M; Watase T; Honda K; Ito R; Kaji K; Urata K; Lee J; Ohara K; Takahashi O; Echizenya S; Iwata K J Dent Res; 2013 Dec; 92(12):1113-7. PubMed ID: 24130220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]